XML 33 R20.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Revenue (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Revenue from Contract with Customer [Abstract] |
Summary of Revenues | The Company recorded the following revenues (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30,
| 2022 |  | 2021 | 2022 |  | 2021
Product sales, net: |  |  |  |  |  |
ORLADEYO | $ | 65,395 |  |  | $ | 36,711 |  | $ | 179,492 |  |  | $ | 76,023 |
RAPIVAB | 6,953 |  |  | 2,430 |  | 7,290 |  |  | 7,165 |
Peramivir | 2,865 |  |  | — |  | 2,865 |  |  | 7,254 |
Total product sales, net | 75,213 |  |  | 39,141 |  | 189,647 |  |  | 90,442 |
Royalty revenue | 600 |  |  | 322 |  | 1,487 |  |  | (447) |
Milestone revenue | — |  |  | — |  | — |  |  | 15,000 |
Collaborative and other research and development revenues: |  |  |  |  |  |
U.S. Department of Health and Human Services | 14 |  |  | 1,531 |  | 148 |  |  | 5,017 |
Total collaborative and other research and development revenues | 14 |  |  | 1,531 |  | 148 |  |  | 5,017 |
Total revenues | $ | 75,827 |  |  | $ | 40,994 |  | $ | 191,282 |  |  | $ | 110,012 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration